Cargando…

TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer

BACKGROUND: Endometrial cancer (EC) is a common tumor of the genital tract that affects the female reproductive system but with only limited treatment options. We aimed to discover new prognostic biomarkers for EC. METHODS: We used mRNA-seq data to detect differentially expressed genes (DEGs) betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Zheng, Hua, He, Hui, Meng, Shuying, Han, Yatian, Su, Zhe, Yan, Hanbing, Zhang, Yanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942693/ https://www.ncbi.nlm.nih.gov/pubmed/35356748 http://dx.doi.org/10.1155/2022/5401106

Ejemplares similares

TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
por: Zhou, Fang, et al.
Publicado: (2020)

TPX2 expression is associated with poor survival in gastric cancer
por: Tomii, Chiharu, et al.
Publicado: (2017)

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer
por: Zou, Jun, et al.
Publicado: (2018)

Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer
por: Zhu, Hongjun, et al.
Publicado: (2020)

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
por: Zhou, Yi, et al.
Publicado: (2014)

HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2
por: Zhong, Xiaodan, et al.
Publicado: (2021)

Prognostic significance of TPX2 and NIBP in esophageal cancer
por: Sui, Chao, et al.
Publicado: (2019)

High expression of TARS is associated with poor prognosis of endometrial cancer
por: Si, Lihui, et al.
Publicado: (2023)

Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer
por: Zhang, Jinxiu, et al.
Publicado: (2019)

Systematic comparison of TPX and TPX3 devices regarding luminosity measurements in the ATLAS cavern
por: Fiedler, Petr
Publicado: (2021)

Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis
por: Zhang, Meng-Yu, et al.
Publicado: (2018)

Therapeutic targeting of the TPX2/TTK network in colorectal cancer
por: Shaath, Hibah, et al.
Publicado: (2023)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer
por: Falcón, O, et al.
Publicado: (1999)

Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis
por: Kojima, Ryuji, et al.
Publicado: (2022)

Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers
por: Okon, Imoh S., et al.
Publicado: (2015)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer
por: Qu, Chong, et al.
Publicado: (2018)

Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
por: Zheng, Ruipan, et al.
Publicado: (2017)

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients
por: Schneider, Marc A., et al.
Publicado: (2017)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Sox2‐dependent inhibition of p21 is associated with poor prognosis of endometrial cancer
por: Yamawaki, Kaoru, et al.
Publicado: (2017)

Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer
por: de Andrade, Diocesio Alves Pinto, et al.
Publicado: (2019)

TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer
por: Wei, Ping, et al.
Publicado: (2013)

Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells
por: Huang, Chaoyou, et al.
Publicado: (2017)

TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer
por: Guenther, Michael, et al.
Publicado: (2023)

TPX2 is a drag on Eg5
por: Leslie, Mitch
Publicado: (2011)

TPX: Biomedical literature search made easy
por: Joseph, Thomas, et al.
Publicado: (2012)

Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer
por: Li, Shen, et al.
Publicado: (2015)

Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Retraction]
Publicado: (2023)

OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer
por: Mao, Min, et al.
Publicado: (2021)

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
por: Yang, Bo, et al.
Publicado: (2014)

THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer
por: Zhang, Shiyu, et al.
Publicado: (2022)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
por: Jin, Tong Yi, et al.
Publicado: (2022)

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
por: Pan, Hung-Wei, et al.
Publicado: (2017)

Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
por: Chang, Ha Kyun, et al.
Publicado: (2023)

CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3leklidkucf00ej7e2prnialaf